Ectoin Patent Landscape
Identifiers
Functions
Which organizations and claims shape current development around ECTOIN?
Bionic Lab Co., Ltd. (바이오닉랩 주식회사) is the assignee shaping current development, with a patent claiming a preparation method for an ectosome-GF complex. The key claims cover a multi-step process: preparing a complex with 0.1–5 parts by weight ectoin, 0.01–3 parts exosome, and 0.001–2 parts growth factor; dissolving ectoin in purified water; forming a primary ectoin-exosome complex under stirring and pH adjustment; and adding AFA extract, cell-penetrating peptide, and hyaluronic acid before homogenization. The claims emphasize process parameters (temperature, time, pH) as the basis for the invention.
How is Ectoin innovation changing in Cosmetics?
Monthly patent filings by domain
Which technical problems do recent patents address with ECTOIN?
Recent patent evidence addresses the technical problem of stabilizing and delivering multiple bioactive agents in a single skin-regeneration composition. The claimed method solves the challenge of combining ectoin with exosomes and growth factors by dissolving ectoin in purified water first, then sequentially mixing the other actives under controlled temperature and pH to form a stable complex. This approach targets skin barrier strengthening and regeneration promotion, implying a need for formulations that preserve the activity of fragile biological components while maintaining a cosmetically and pharmaceutically acceptable product.
How do recent patents change the role or application of ECTOIN?
Recent patents reposition ectoin from a standalone protective or moisturizing agent to a foundational structural component in a multi-component delivery complex. In the claimed approach, ectoin is not merely an active ingredient but serves as the initial solubilizing and complexing base that enables subsequent binding with exosomes and growth factors. This changes its role from a passive stabilizer to an active participant in forming a supramolecular assembly, potentially enhancing the delivery and synergistic activity of co-formulated biological actives for skin barrier repair.
How is Ectoin used in Cosmetics patents?
Which Cosmetics product categories feature Ectoin in recent patents?
Which product categories and formulation strategies emerge in recent work on ECTOIN?
The emerging product category is a skin regeneration composition spanning both cosmetics and pharmaceuticals, with a formulation strategy centered on a sequential complexation process. The claimed method involves dissolving ectoin in purified water at 5–25°C, adding exosomes under pH control (5.0–7.5), then incorporating growth factors, followed by Aphanizomenon flos-aquae extract, cell-penetrating peptides, and hyaluronic acid. This approach emphasizes low-temperature processing, pH adjustment, and homogenization to create a stable ectosome-GF complex, suggesting a strategy for combining small molecules with biological actives in a single formulation.
Where is the evidence-backed white space for further development of ECTOIN?
The evidence-backed white space lies in exploring ectoin's role in stabilizing biological actives beyond the specific exosome-growth factor combination claimed. Since the only patent focuses on a fixed complex with AFA extract, cell-penetrating peptides, and hyaluronic acid, there is room to investigate alternative co-ingredients or delivery formats that could leverage ectoin's complexing properties. Additionally, the absence of concentration ranges in the claims suggests an opportunity to optimize ectoin levels for different skin conditions or product types, though the evidence does not specify which alternatives would be viable.